Photo of John Joyce
R United States House · District 13 · Pennsylvania On the 2026 ballot

Rep. John Joyce

Compare
Total votes
2,818
all sessions
Attendance
100%
6 missed
Higher than 93% of chamber peers
With party
93%
of cast votes
Lower than 77% of chamber peers
Bipartisan score
4%
crosses aisle rarely
Higher than 76% of chamber peers
Sponsored
637
bills & resolutions
Lower than 81% of chamber peers
Committees
4
assignments
637 bills and resolutions

Sponsored bills

Total
637
Primary
56
Co-sponsor
581
This page
637
matching current filters
Co-sponsor HR 452
Signed into law · Nevada House · Co-sponsor
Miracle on Ice Congressional Gold Medal Act

Miracle on Ice Congressional Gold Medal Act This act provides for the award of Congressional Gold Medals to the members of the 1980 U.S. Olympic men's ice hockey team in recognition of the team's achievement at the 1980 Winter Olympic Games.

Signed into law Dec 12, 2025 1 co-sponsor
Co-sponsor HR 1461
Passed · Nevada House · Co-sponsor
To designate the facility of the United States Postal Service located at 521 Thorn Street in Sewickley, Pennsylvania, as the Mary Elizabeth Bettie Cole Post Office Building.

Maddy summaryHR 1461 designates the U.S. Postal Service facility at 521 Thorn Street in Sewickley, Pennsylvania, as the "Mary Elizabeth 'Bettie' Cole Post Office Building." The bill updates all official references to this specific post office location to reflect the new name. This is a ceremonial naming resolution honoring Mary Elizabeth "Bettie" Cole, with no new policies, funding, or operational changes to the postal facility.

Passed Dec 10, 2025 1 co-sponsor
Co-sponsor HR 1949
Passed · Nevada House · Co-sponsor
Unlocking our Domestic LNG Potential Act of 2025

Maddy summaryThis bill amends the Natural Gas Act to give the Federal Energy Regulatory Commission (FERC) exclusive authority to approve U.S. LNG export terminal projects, requiring FERC to deem such exports consistent with the public interest. It directly affects natural gas companies seeking to build or expand export facilities and streamlines FERC's review process by removing prior requirements for interagency coordination. The bill clarifies that FERC's decisions won't override existing sanctions laws, including restrictions on trade with countries designated as state sponsors of terrorism under current law. This change aims to accelerate domestic LNG export projects while maintaining legal safeguards for national security and foreign policy.

Passed Dec 8, 2025 1 co-sponsor
Primary HR 6046
In committee · Nevada House · Lead sponsor
Broadband and Telecommunications RAIL Act

Maddy summaryThis bill streamlines the process for broadband providers to install facilities in public rights-of-way near rail corridors and on railroad property. It requires providers to notify railroads when placing facilities in intersecting areas (with specific details) and to submit formal applications for railroad rights-of-way, including engineering plans and safety details. Railroads can only deny applications for safety reasons (like infrastructure damage or passenger risk) and must charge providers only for actual safety-related costs. Disputes over approvals or fees are resolved by the FCC within 90 days, with railroads and providers required to follow safety standards and industry guidelines. The law aims to balance broadband expansion with railroad safety and operational needs.

In committee Dec 3, 2025 0 co-sponsors
Co-sponsor HR 4077
In committee · Nevada House · Co-sponsor
GUARD Veterans’ Health Care Act

Maddy summaryThis bill requires Medicare Advantage and prescription drug plans to reimburse the Department of Veterans Affairs (VA) for health care services provided to veterans enrolled in those plans, including outpatient care, prescription drugs, and inpatient services. It establishes a new process for the VA to recover costs from Medicare plans, requiring these plans to respond to reimbursement claims within 45 days and face penalties for non-compliance, including triple damages for willful violations. The law modifies existing VA authority to recover costs for non-service-connected disabilities by clarifying recovery procedures and requiring Medicare plans to coordinate benefits with VA care. The provisions apply to Medicare plan years beginning January 1, 2026, and directly affect Medicare Advantage organizations and prescription drug plan sponsors that serve veterans. This policy change ensures veterans receive full benefits without double payments by requiring Medicare plans to reimburse the VA for services they cover.

In committee Dec 3, 2025 1 co-sponsor
Co-sponsor HR 1262
Passed · Nevada House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 6219
In committee · Nevada House · Co-sponsor
Conscience Protections for Medical Residents Act

Maddy summaryThis bill prohibits Medicare-approved medical residency programs from requiring residents to undergo abortion training without their voluntary consent. It specifically bans programs from making such training mandatory (requiring residents to "opt-in" rather than "opt-out") or from discriminating against residents who refuse this training or do not perform abortions. The law directly affects medical residents in Medicare-funded postgraduate training programs across the U.S., ensuring they cannot be forced into abortion-related clinical experiences or penalized for declining them.

In committee Nov 20, 2025 1 co-sponsor
Primary HR 6197
In committee · Nevada House · Lead sponsor
Health Tech Investment Act

Maddy summaryHR 6197, the Health Tech Investment Act, establishes a new payment category under Medicare for algorithm-based healthcare services (like AI tools used in diagnosis or treatment) starting January 1, 2026. It requires Medicare to pay based on manufacturer-provided costs (including software, staff, and overhead) for these services and prohibits removing them from the special payment category for at least five years after initial payment. This directly affects Medicare beneficiaries (through coverage), healthcare providers (who deliver these services), and AI/algorithm service manufacturers (who receive reimbursement). The bill ensures these new technologies get fair payment while gathering sufficient claims data before potentially moving them to standard payment categories.

In committee Nov 20, 2025 0 co-sponsors
Co-sponsor HR 6019
Passed · Nevada House · Co-sponsor
To repeal certain provisions relating to notification to Senate offices regarding legal process on disclosure of Senate data, and for other purposes.

Maddy summaryHR 6019 repeals a requirement that Senate offices must be notified when legal requests seek Senate data. Specifically, it removes Section 213 of the 2026 appropriations act, which mandated that Senate offices be informed about legal processes requesting disclosure of Senate data. This change directly affects Senate offices by eliminating a procedural notification step for legal requests involving their data. The bill makes no other policy changes, solely removing this specific administrative requirement.

Passed Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6130
In committee · Nevada House · Co-sponsor
ASAP Act

Maddy summaryThis bill would require Medicare to cover early detection screening tests for Alzheimer's disease and related dementias starting January 1, 2028. It defines eligible tests as FDA-cleared genomic blood tests, blood product analyses, or equivalent medical imaging methods (like protein expression or whole genome sequencing) that detect pre-symptomatic or early-stage conditions. Medicare beneficiaries would receive this coverage without cost-sharing for these specific screenings. The bill amends Medicare coverage rules to explicitly include these tests under Section 1861(nnn) of the Social Security Act.

In committee Nov 19, 2025 1 co-sponsor
Showing 51 to 60 of 637 bills
Previous 1 5 6 7 64 Next